Detection of invasive Trichosporon asahii in patient blood by a fungal PCR array

Jasmin K Weber1, Sebastian Scharf1, Grit Walther2

  • 1Institute for Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Access Microbiology
|January 13, 2022
PubMed

Insights

Diagnosing rare invasive fungal infections like Trichosporon asahii is challenging. A new fungal PCR array offers faster identification, potentially improving treatment outcomes for immunocompromised patients.

Area of Science:

  • Mycology
  • Medical Diagnostics
  • Infectious Diseases

Background:

  • Invasive fungal infections (IFIs) pose a significant threat to immunocompromised individuals.
  • Timely diagnosis of IFIs is often hindered by non-specific clinical presentations and limitations of conventional identification methods.
  • Delayed diagnosis can lead to ineffective treatments and poor patient outcomes.

Observation:

  • A young adult with Hodgkin lymphoma developed a disseminated Trichosporon asahii infection.
  • Standard diagnostic methods, including culture and MALDI-TOF, identified T. asahii, but the patient succumbed to multi-organ failure.
  • A retrospectively applied experimental fungal PCR array on an EDTA blood sample was evaluated.

Findings:

  • The experimental PCR array utilized two pan-fungal and seven species-specific reactions.
  • This PCR array demonstrated the potential to significantly reduce the time required for diagnosing invasive T. asahii infections.
  • The diagnostic approach could facilitate earlier targeted therapy with triazoles.

Implications:

  • Faster and more accurate diagnosis of rare IFIs is crucial for effective patient management.
  • The developed PCR array shows promise as a valuable tool for rapid identification of T. asahii.
  • Advancements in molecular diagnostics can improve survival rates for patients with severe fungal infections.